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Abstract

This research aims to evaluate the mechanical properties, biocompatibility, and degradation behavior
of scaffolds made of pure hydroxyapatite (HA) and HA‐modified by ZnO for bone tissue engineering
applications. HA and ZnO were developed using sol‐gel and precipitation methods respectively. The
scaffolds properties were characterized using X‐ray diffraction (XRD), Fourier transform spectroscopy
(FTIR), scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), transmission
electron microscopy (TEM), atomic absorption (AA), and atomic force microscopy (AFM). The
interaction of scaffold with cells was assessed using in vitro cell proliferation and alkaline phosphatase
(ALP) assays. The obtained results indicate that the HA/ZnO scaffolds possess higher compressive
strength, fracture toughness, and density—but lower hardness—when compared to the pure HA
scaffolds. After immersing the scaffold in the SBF solution, more deposited apatite appeared on the
HA/ZnO, which results in the rougher surface on this scaffold compared to the pure HA scaffold.
Finally, the in vitro biological analysis using human osteoblast cells reveals that scaffolds are
biocompatible with adequate ALP activity.
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INTRODUCTION

Bioceramics have been widely used in medicine and dentistry. One remarkable success of bioceramics
is the emergence and clinical use of bioactive ceramics.1 Over the past 20 years, a wide range of
calcium phosphates—such as hydroxyapatite (HA),2‐4 amorphous calcium phosphate,5‐8 tetra‐calcium
phosphate,9 and mono‐di calcium phosphate10‐12—has been studied in both dentistry and in
orthopedics fields. Micro or nanoscale HA have been investigated, and their mechanical properties
have been tested.13 Calcium phosphates are primarily used for bone replacement, since they are
biocompatible, have a low density, have excellent chemical stability and are similar in chemical
composition to the bone mineral phase. Among calcium phosphates, HA is stoichiometric,
biocompatible, osteoconductive, nontoxic, noninflammatory, nonimmunogenic, and biologically
active.14 This means that it is capable of direct chemical bonding with living tissue.14 Micro HA is used
in the shape of thin‐film coating, powder, porous scaffolds, and dense blocks.15 Because of its
bioavailability, HA can be used as the material for bone implants; over the time, it can help bone
production. The bioavailability of HA can be increased by increasing its crystallinity degree and
reducing its grain size.16 The rate of calcium dissolution, however, is one of the HA's weaknesses in
clinical applications that needs to be corrected.17 Osteoconductive properties associated with HA are
attributed to its dissolution behavior in the human body. Proper structural change is one of the ways to
increase the dissolution rate of HA.17
Zinc (Zn) is one of the metal elements in the human body that is essential for bone structure and
metabolism.18 The bone mineral has the largest amount of this element (ie 160‐300 ppm). Zn also plays

a role in cell differentiation, the growth and metabolism of proteins, carbohydrates, and lipids. It also
plays a role in the structure of hormones and genetic transcription, while also contributing to the
synthesis and degradation of nucleic acids, carbohydrates, lipids and proteins, and many vital
reactions. Studies on the role of Zn on stimulating bone growth in vitro and in vivo have shown that it
reduces the bone deterioration by preventing osteoclast and ALP activity.19 Zn also stimulates collagen
formation and development of bone growth proteins, such as osteocalcin, IGF‐1, TGR‐f, and aminoacyl‐
tRNA.20 Zn ion is not only useful for bone regeneration but also is anti‐inflammatory.
Zn also has antibacterial properties and is an essential metal element for cell growth and regeneration
of extracellular matrix; therefore, Zn can improve the bone tissue repair process and has been used in
bioactive glasses.21 ZnO nanoparticles also exhibit antibacterial activity. The reason for the antibacterial
activity of ZnO is due to its ion release or reactive oxygen species generation.22 Recent studies have
shown that the use of ZnO nanoparticles increases the proliferation of bone cells and contributes to
bone growth. The above‐mentioned benefits of ZnO are strongly dependent on their release behavior.
Hence, the release rate of ZnO should be carefully controlled.22
Ching et al prepared HA nanoparticles with a wet chemical method and blended them with commercial
ZnO with different weight percentages below 1% of ZnO.23 Safari Gezaz et al prepared nano‐HA
particles and nano‐ZnO with a sol‐gel method, separately, and blended them in different weight
percentages from 0% to 100% ZnO.24 They only investigated mechanical properties, and their
nanocomposite fabrication process was blending. Vijaykumar et al doped ZnO nanoparticles to HA and
prepared nanofibrous particles to investigate mechanical properties and viability.25 In this study, it is
intended to modify the HA nanoparticles prepared by sol‐gel method with ZnO nanoparticle
precipitation. To construct the scaffolds, we used the cold isostatic pressure (CIP), and then the
specimens were sintered at 1300°C. Microstructure, biodegradability, biocompatibility, and mechanical
properties of scaffolds were then investigated.

MATERIALS AND METHODS
Material preparation
Hydroxyapatite (HA) synthesis
Nano‐HA was prepared using the sol‐gel method, as previously described.26 Briefly, Ca(NO3)2·4H2O
(0.1 mol/L) and (NH4)2HPO4 (0.06 mol/L) were dissolved in deionized water separately, and the pH of
both solutions was adjusted to 11.0 by adding ammonia solution. The solution of Ca(NO3)2·4H2O was
dropwise added into the (NH4)2HPO4 solution for 1 hour, and the white suspension and gelatinous
precipitate were obtained. After aging for 24 hours at room temperature, the precipitates were
filtered, washed several times with distilled water and absolute ethanol, dried at 80°C overnight, then
calcined at 800°C for 2 hours.
Preparation of ZnO modified‐HA powder
A Zn(NO3)2.6H2O (0.267 g, 0.897 mmol) solution was precipitated with NaNO3 (1 mol/L) at room
temperature and pH of 8. Nano‐HA (2 g) was then added into the precipitated Zn(OH)2, followed by
constant stirring for 2 hours at 70°C‐80°C. Finally, the white precipitates were washed with deionized
water and dried at 80°C overnight. The obtained powder was calcined at 450°C for 2 hours.27

Preparation of ZnO modified‐HA scaffolds
The prepared ZnO modified‐HA powder was cold isostatic pressed (CIP) at 250 MPa. The pressed
powder was then sintered at 1300°C for 2.5 hours in a box furnace at a heating rate of 5°C/min. Next,
the samples in the shape of circular discs were produced for hardness or compression tests.

Material characterization

To investigate the phase composition of extracted HA powder, X‐ray diffraction (XRD: Bruker‐AXS‐D8‐
Discover) analysis was carried out before and after sintering the HA. The XRD details are described in
the Supplementary Material 1.
To identify the existence of organic species, along with the degree of probable dehydroxylation of HA
during the heat treatment, we performed Fourier transform infrared analysis (FTIR: Shimadzu 8300).
The FTIR details are described in the Supplementary Material 1.
A scanning electron microscope (SEM) equipped with energy dispersive spectroscopy (EDS) was used
to examine the morphology of the powder and scaffolds. The porosity of scaffolds was also
investigated by SEM.
Topography and surface roughness of the scaffolds, plus the particle size of the produced powder were
measured by an atomic force microscopy (AFM; Alpha 300A WITec Germany). The non‐contact mode
was considered and 3D images were presented in the area measuring 1 × 1 µm2.
A transmission electron microscope (JEOL JEM‐2100 TEM) was used to assess the nanoparticles'
morphology and size in the ZnO modified HA scaffolds.
To determine ZnO within the ZnO modified HA scaffolds, an AA680 atomic absorption/flame emission
spectrophotometer (Shimadzu) was used.

Mechanical properties

Mechanical properties of the samples were evaluated with compressive and hardness tests. The
compressive test was performed on cylindrical samples (10 mm in diameter × 10 mm in length) using a
universal testing machine (Zwick, Material Prufung, 1446e60) with a 10 kN load cell. Although the best
sample for a compression test is a diameter‐to‐height ratio of 1/2, but in the ceramic samples, we can
also test the compression with a diameter‐to‐height ratio of 1.28 The crosshead speed was
0.5 mm/min. The surface area under the stress‐strain curves was calculated and considered as the
fracture toughness of the samples. Disc shape samples were selected for microhardness test (16 mm
diameter × 4 mm height). The microhardness (Hv) of the polished sintered samples was determined via
the Vickers indentation (MHV1000Z) using an applied load of 200 g with a dwell time of 10 seconds.
The density of samples was measured by the Archimedes method.

In vitro biodegradability

The sintered HA samples were soaked in 20 mL of simulated body fluid (SBF) with pH 7.40 and specific
ion concentrations nearly identical to those in human blood plasma (Na+ 140.3 mm, K+ 5.3 mm, Mg2+
1.3 mm, Ca2+ 2.2 mm, Cl− 148.0 mm, HCO3− 4.0 mm, HPO42− 0.8 mm, SO42− 0.5 mm). After the samples
were kept at 37°C for 28 days, they were removed from SBF, gently rinsed with distilled water and

dried at room temperature. Changes in the surface morphologies of samples before and after soaking
in the SBF were characterized by SEM and EDX.

Cell culture

To sterilize the samples, they were immersed in 70% ethanol three times, followed by washing with
phosphate buffer saline (PBS) for 15 min/cycle. Culture medium was prepared from Dulbecco's
Modified Eagle Medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS, Sigma) and
1% Penicillin‐Streptomycin (Invitrogen). 5 × 105 Human Osteoblast Cells (HOB, Cell Applications) were
cultured on the samples immersed in growth medium. The medium was refreshed every 2 days.
The morphology of HOB cells cultured on the samples was studied by scanning electron microscopy
(SEM, JEOL JSM‐6510LV) after 14 days' culture. The cell culture details are described in the
Supplementary Material 1.
The fluorescence intensity (Ex: 560 nm and Em: 590 nm) was measured by a spectrophotometric plate
reader (Synergy HTX, BioTEK). Triplicate samples were used for this experiment.

Alkaline phosphatase activity (ALP)

ALP of HOB seeded samples was performed using an ALP assay kit (Abcam) after 14 days. The seeded
cells on the samples were lysed with RIPA Lysis and Extraction Buffer (Invitrogen). 50 μL of lysate was
reacted with 150 μL of p‐nitrophenyl phosphate (p‐NPP) for 45 minutes at 37°C. The reaction was
terminated with a stop solution, and the absorbance intensity of p‐nitrophenol was determined at
405 nm, using a microplate reader (Synergy HTX, BioTEK). The details of the ALP and statistical analysis
are described in the Supplementary Material 1.

RESULTS AND DISCUSSION
FTIR analysis

The stretching band at 3426.89 cm−1 and liberation band at 632.537 cm−1 originate from OH− groups.
The bands located at 472.474, 568.798, 601.682, 1039.44, and 1091.51 cm−1 originate from PO43‐ ions,
and are weaker than the strong P‐O stretching vibration due to HA stoichiometry. The bands at
1400.07 and 1614.13 cm−1 originate from CO32− ions (Figure 1A). Carbonate ions are a common
impurity in both synthetic and natural HA.28 The FTIR spectrum of the sample that was heat‐treated at
800°C is in good agreement with the spectrum reported by Heidari et al28 for natural HA material (see
Figure 1A).

1 FTIR analysis of (A) HA, (B) HA/Zn powder

Figure 1B shows the spectra of the composite of HA/ZnO. Given that the Zn‐O vibration bond occurs at
a wavelength of 575 cm−1,29 the sharp peak in this diagram at wavelength 566.969 cm−1 is related to
vibration of the zinc‐oxygen bond.

XRD analysis

Figure 2A,B show the XRD analysis for pure HA and HA/ZnO. The XRD pattern of these samples shows
the following broad diffraction peaks at 26.172°, 28.25°, 29.1°, 31.9°, 32.35, 33°, 34.2°, 39.96°, 46.85°,
48.25°, 50.65°, 51.4°, 52.35°, 63.1°, and 53.38° (Figure 2A). All reflections are characteristics of the
hexagonal phase of HA [Ca10(PO4)6(OH)2], according to the standard data (JCPDS No. 74‐0566).30 The
obtained patterns are in agreement with Kim et al31 and Heidari et al.32,33

2 The XRD results for (A) HA powder synthesized by the sol‐gel method; (B) HA powder synthesis by sol‐gel
method and modified by ZnO; (C) HA/ZnO scaffold prepared by CIP method and sintered at 1300°C

As shown in Figure 2B, the diffraction pattern does not indicate the ZnO peak, which can be due to the
low percentage of ZnO in the HA/ZnO composite. Figure 2C shows the XRD pattern of HA/ZnO
composite, which was prepared by a cold isostatic pressing method and followed by a sintering process
at 1300°C. As shown in the XRD pattern, the main peaks of HA still exist, and no new peak related to
tricalcium phosphate was detected. However, a lower peak intensity was observed from HA/ZnO
composite (Figure 2C) compared to its powder (Figure 2B), which can be due to undeveloped grain
growth in the samples sintered at 1300°C.34

Atomic absorption analysis

Atomic absorption analysis was performed on ZnO‐modified HA powder. First, 0.3 g of this powder was
dissolved in 25 cc solvent (chloridric acid), and the concentration of Zn2+ ion was estimated to be
0.191 mg/L. This estimate is for a liter of solvent equivalent to 4.77 × 10−3 mg zinc ions. As 0.02 g of
powder for atomic absorption was used, the percentage of total Zn2+, Ca2+, and Pd2+ ions in the whole
powder would be 0.06, 29.15, and 0.095 percent. The molecular mass of Zn is 65.4 g/mol, while the
molecular mass of oxygen is 16 g/mol; therefore, the percentage of ZnO deposited on HA is equal to
81.65 × 0.016%, which is approximately 0.02%.
The molecular weight of Zn(NO3)2.6H2O, which is equal to 297.4 g/mol, and the amount of 0.267 g of
this salt was used in this study. Therefore, the Zn2+ contribution is 0.058%, which, in proportion to the

initial HA weight used (2 g), should be in the composite 0.028%, while according to the results of
atomic absorption the Zn2+ concentration is equivalent to 0.016%. Thus, as much as 0.012% zinc ions
are lost, which can be due to the incomplete deposition of the Zn(OH)2 in the presence of HA powder
after the addition of ammonia in solution.

Scanning electron microscope images

Figure 3A‐C show the SEM images of HA/ZnO powder and the cross‐sectional area of the pure HA and
HA/ZnO composite samples sintered at a temperature of 1300°C. According to Figure 3A, the size of
agglomerated powder particles is 2 ± 0.5 µm. Results show that modification of HA with ZnO reduces
the porosity of HA (Figure 3B) and enhances its sinterability (Figure 3C).

3 SEM images of (A) HA/ZnO powder (top view), (B) HA scaffold (cross‐sectional view) and (C) HA/ZnO scaffold
(cross‐sectional view)

Transmission electron microscope images

According to TEM images, the HA/ZnO nanoparticles have a spherical shape with an average particle
size of less than 80 nm (Figure 4A). In high magnification TEM images, the average size of ZnO
nanoparticles on the surface of HA is 10 nm.

4 TEM images of HA/ZnO in (A) low and (B) high magnification, showing the morphology and size of
nanoparticles

Mechanical testing

Heidari et al reported that HA samples extracted from the cattle bone—pressed with a CIP method and
sintered at 1300°C—have a compressive strength of 3.25 aPM and a fracture toughness of 0.3 aPM.28
However, in this study, with the same manufacturing conditions, the compressive strength of the pure
HA sample obtained is 22.4 MPa, while the fracture toughness is reduced to 0.168 MPa (Table 1).
Furthermore, hardness in these specimens has been shown to increase by 1 GPa than those made from
natural HA. These changes are likely due to the HA powder, which had been synthesized by the sol‐gel
method, and the size of the powder was smaller compared to HA used in our previous study.28 Teh et
al reported that ZnO increases the density of HA. Increasing the temperature of the sintering also

increases the density. Up to 1250°C, the addition of 0.1% ZnO to HA increases the density to 99.1%.
This causes an increase in fracture toughness by 0.2 MPam1/2, while the hardness remains constant.35
Addition of 0.02% ZnO to HA results in a reduction in hardness (from 4.26 to 3.14 GPa), an increase in
density (from 2.83 to 2.86 g/cm3), an increase in compressive strength (from 22.4 to 23.2 MPa), and an
increase the fracture toughness (from 0.168 to 0.232 MPa) of the samples (Table 1). Hence, our results
show that ZnO increases the fracture energy of the samples due to the condensation of the samples
under the same conditions of production.
1 TABLE Mechanical properties of HA and ZnO modified HA scaffolds
Density Hardness Fracture TOUGHNESS (MPa) Fracture strength (MPa)
(g/cm3) (GPa)
2.83
4.26
0.168
22.4
HA
2.86
3.14
0.232
23.2
HA/ZnO

Immersion in SBF solution

Figure 5A shows the surface topography of the HA powder prepared by the sol‐gel method. The results
of the AFM analysis indicates that the HA particle size is in the range of 90 to 110 nm. This range of
particle size is much smaller than the particle size range of HA powder extracted from the cattle bone
reported by Heidari et al, which was about 5 μm.32

5 Analysis of surface topography using AFM from (A) sol‐gel synthesized HA powder, (B) surface of pure HA
scaffold before immersion, (C) surface of HA/ZnO scaffold before immersion, (D) surface of pure HA scaffold
after immersion, and (E) surface of HA/ZnO scaffold after immersion in the SBF solution

The surface roughness of the HA scaffolds is shown in Figure 5B. The mean roughness of the samples
before and after immersion in SBF indicated in Table 2. Figure 5C shows the AFM graph of HA/ZnO,
when the roughness of ZnO deposited on HA has increased from 620.7 to 773.9 nm (Table 2). Figure 5D
shows the AFM graph of the surface of the pure HA sample after immersion. Surface roughness
decreases by 236.2 nm, compared to before immersion. Figure 5E shows the surface of the HA/ZnO
sample. The surface roughness in this sample has increased from 773.9 to 1503 nm (Table 2). Our

results show that ZnO can increase apatite deposition on the surface of HA scaffolds. Usually at
roughness more than 50 nm, van der Waals forces are the main factor; while at closer distances (10‐
20 nm), a combination of both van der Waals forces and electrostatic interactions controls cell
adhesion.36 For metals used in medical implants, the desired surface roughness is usually below
10 nm.37 Rough surface promotes friction, thus reduces the mobility of the bacteria; this sessile
environment facilitates the biofilm growth.38 Hence, HA and HA/ZnO have a significant surface
roughness and can be a good place for cell proliferation.
2 TABLE The amount of roughness of surface samples
Samples Surface Roughness Before
Surface Roughness After
Immersion (nm)
Immersion (nm)
HA
620.7
384.5
HA/ZnO 773.9
1503

Change in Roughness
(nm)
−236.2
+729.1

Figure 6A,B indicate the SEM images of HA and HA/ZnO after 28 days immersion in SBF. This image
shows that apatite deposition on pure HA is completely uniform, but Figure 6B indicates the increase in
the surface roughness of HA/ZnO.

6 SEM images from the surface of the scaffold after 28 d of immersion in SBF solution, (A) pure HA, (B) HA/ZnO,
(C) EDS analysis of the deposited layer on the surface of HA/ZnO scaffold

The formed apatite has been further analyzed and confirmed by EDS, showing the main elements are
calcium and phosphorus (Figure 6C). Also, other elements (chlorine and sodium) are detected in our
EDS analysis, which can be due to the NaCl in the SBF solution.

Cell culture

ALP is believed to be upregulated in the early stages of biomineralization in order to form a large pool
of inorganic phosphate from which HA can be mineralized.39 After the onset of mineralization, ALP is
no longer needed, and therefore, cellular levels of the enzyme drop before a mature mineralized
matrix are formed.40 Figure 7 shows the results of ALP after 14 days. The statistical analysis showed
that the ALP activity for pure HA sample was higher than the HA/ZnO ones.

7 ALP assessment on HA and HA/ZnO scaffolds (14 d)

Figure 8 shows the proliferation of human osteoblast cells on the surface of the scaffold. Darker graphs
appear after 7 days, and more explicit graphs after 14 days in the culture medium. The density of the
cells cultured on both samples significantly increased after 14 days than 7 days. Generally, the
proliferation of cells on pure HA was higher than that of HA/ZnO, however, both samples show
significantly higher cellular viability after 14 days compared to the control sample (P < .05).

8 Cell proliferation diagrams on HA and HA/ZnO scaffolds after 7 (darker) and 14 d (clearer graphs)

In such conditions, we should know that at some concentrations, Zn ions could also have adverse
effects on the cells. Although Jafarirad et al showed that the negative charge of ZnO nanoparticles at
concentrations of 0.05 and 0.1 mg/mL induced very low toxicity on cancer cell lines, another study
reported toxicity of ZnO particles towards epithelial cells.41,42
One limitation of our study is not considering the amount of deposited and released Zn ion from our
samples. Grenho et al measured the Zn ion release and showed a slight increase of the release of Zn
ions in nano‐HA granules with 2% ZnO from 0.30 to 0.38 ppm, from day 1 to day 3 respectively. This
amount in day 3 caused an inhibitory effect on MG63 cells and caused lower cell proliferation 43. Also,
Li et al reported good reproduction behavior of L929 cell line at lower ZnO nanowires concentration
and considerable viability drop (∼50%) at concentrations close to 100 µg/mL.44 One study showed that
structural modifications in lattices of ZnO could decrease its solubility and, therefore, reduce its
cytotoxicity.45 Future studies are recommended for measurement of the released Zn ion from HA/ZnO
constructs and screening the best concentration. Furthermore, the efficacy of these samples against
different bacteria might be assessed.

Figure 9 shows SEM images of human osteoblast cells attached to the surface of the specimens after
14 syad, confirming the biocompatibility of our HA and HA/ZnO scaffolds.

9 SEM images from the cells attached surface of the specimens after 14 d of culture: (A) pure HA scaffold, (B)
HA/ZnO scaffold

CONCLUSION

HA powder was synthesized by sol‐gel method and modified with ZnO deposition. Scaffolds were then
made using the CIP method, followed by sintering at 1300°C. Modification of HA with ZnO increases
the compressive strength, fracture toughness and density. Results of surface topography show that the
HA/ZnO scaffold is rougher than the pure HA one. After immersion in the SBF solution, more apatite is
deposited on the surface of the HA/ZnO compared to HA bioscaffold. The results of cell attachment
and proliferation prove the biocompatibility of our HA/ZnO bioscaffolds.
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